MEDITECH(SH:603990) Xin Lang Cai Jing·2026-01-07 01:26Group 1 - The core viewpoint of the news is that Meditech experienced a decline in stock price and trading volume, with significant changes in financing and stockholder metrics [1][2]. - On January 6, Meditech's stock fell by 0.65%, with a trading volume of 274 million yuan. The financing buy-in amount was 21.23 million yuan, while the financing repayment was 32.91 million yuan, resulting in a net financing buy of -11.68 million yuan [1]. - As of January 6, the total balance of margin trading for Meditech was 268 million yuan, with a financing balance of 267 million yuan, accounting for 5.71% of the circulating market value, indicating a high level compared to the past year [1]. Group 2 - As of September 30, the number of shareholders for Meditech increased to 38,900, a rise of 7.17%, while the average circulating shares per person decreased by 6.69% to 7,864 shares [2]. - For the period from January to September 2025, Meditech reported operating revenue of 22.3 million yuan, a year-on-year decrease of 38.13%, while the net profit attributable to the parent company was 34.27 million yuan, showing a year-on-year increase of 120.49% [2]. - Meditech has cumulatively distributed dividends of 71.36 million yuan since its A-share listing, with no dividends distributed in the last three years [3].